About ArcherDX
ArcherDX is a company based in Boulder (United States) founded in 2013 by John Iafrate and Long Phi Le was acquired by Invitae in June 2020. ArcherDX has raised $152.6 million across 3 funding rounds from investors including Invitae, Driehaus and Perceptive Advisors. The company has 429 employees as of December 31, 2022. ArcherDX has completed 1 acquisition, including Baby Genes. ArcherDX operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, Prenetics and Veracyte, among others.
- Headquarter Boulder, United States
- Employees 429 as on 31 Dec, 2022
- Founders John Iafrate, Long Phi Le
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Archerdx, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$152.6 M (USD)
in 3 rounds
-
Latest Funding Round
$55 M (USD), Series C
Dec 17, 2019
-
Investors
Invitae
& 9 more
-
Employee Count
429
as on Dec 31, 2022
- Investments & Acquisitions
-
Acquired by
Invitae
(Jun 22, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of ArcherDX
Unlock access to complete
Funding Insights of ArcherDX
ArcherDX has successfully raised a total of $152.6M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $55 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ArcherDX
ArcherDX has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Invitae, Driehaus and Perceptive Advisors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked | |
|
Venture capital is offered by Boulder Ventures for innovative companies.
|
Locked | Locked | Locked |
Investor details for ArcherDX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ArcherDX
ArcherDX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Baby Genes.
Investment portfolio details for ArcherDX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genomic diagnostic solutions for neonates and carrier testing are provided.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for ArcherDX
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - ArcherDX
Detailed financials for ArcherDX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Archerdx Comparisons
Peer comparison for ArcherDX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ArcherDX
ArcherDX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, Prenetics and Veracyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are developed.
|
Detailed competitors of ArcherDX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Archerdx
Complete news archive for ArcherDX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ArcherDX
ArcherDX was founded in 2013 and raised its 1st funding round 5 years after it was founded.
ArcherDX is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
ArcherDX is a funded company, having raised a total of $152.6M across 3 funding rounds to date.
As of Dec 31, 2022, the latest employee count at ArcherDX is 429.
ArcherDX was founded in 2013 in Boulder, United States, within the biotechnology sector. Patented Anchored Multiplex PCR (AMP) technology is employed to create in-vitro diagnostics and Personalized Cancer Monitoring products for identifying solid tumor biomarkers. Operations focus on molecular diagnostics for oncology, with a product pipeline that includes ArcherMET, NTRK CDx, and Fusion Plex.
ArcherDX's top competitors include Guardant Health, Exact Sciences and Foundation Medicine.
ArcherDX has made 1 acquisition, including Baby Genes.
ArcherDX has 10 investors. Key investors include Invitae, Driehaus, Perceptive Advisors, ArrowMark Partners, and Soleus Capital.